 | Up a level |
Gueresir, Erdem, Lampmann, Tim 
ORCID: 0000-0002-2607-2024, Bele, Sylvia, Czabanka, Marcus, Czorlich, Patrick ORCID: 0000-0003-0865-241X, Gempt, Jens, Goldbrunner, Roland, Hurth, Helene, Hermann, Elvis, Jabbarli, Ramazan, Krauthausen, Marius, Koenig, Ralph, Lindner, Dirk, Malinova, Vesna, Meixensberger, Jurgen, Mielke, Dorothee, Nemeth, Robert, Oppong, Marvin Darkwah, Pala, Andrej, Prinz, Vincent, Rashidi, Ali, Roder, Constantin, Sandalcioglu, Ibrahim Erol, Sauvigny, Thomas, Schebesch, Karl-Michael, Timmer, Marco, Vajkoczy, Peter, Wessels, Lars, Wild, Florian, Wilhelm, Christoph, Wostrack, Maria, Vatter, Hartmut and Coch, Christoph
(2023).
Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
Int. J. Stroke, 18 (2).
S. 242 - 248.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1747-4949
Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias ORCID: 0000-0002-0788-0317, Schuss, Patrick ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias
(2022).
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials, 23 (1).
LONDON:
BMC.
ISSN 1745-6215